These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32149140)

  • 1. Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics.
    Abas M; Rafique H; Shamas S; Roshan S; Ashraf Z; Iqbal Z; Raza H; Hassan M; Afzal K; Rizvanov AA; Asad MHHB
    Biomed Res Int; 2020; 2020():8104107. PubMed ID: 32149140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: synthesis of Schiff bases of hydroxybenzaldehydes with aromatic sulfonamides and their reactions with arylsulfonyl isocyanates.
    Scozzafava A; Banciu MD; Popescu A; Supuran CT
    J Enzyme Inhib; 2000; 15(6):533-46. PubMed ID: 11140609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT
    Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.
    Nasr G; Cristian A; Barboiu M; Vullo D; Winum JY; Supuran CT
    Bioorg Med Chem; 2014 May; 22(10):2867-74. PubMed ID: 24746465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
    Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate.
    Sağlık BN; Osmaniye D; Çevik UA; Levent S; Çavuşoğlu BK; Büyükemir O; Nezir D; Karaduman AB; Özkay Y; Koparal AS; Beydemir Ş; Kaplancıklı ZA
    Eur J Med Chem; 2020 Jul; 198():112392. PubMed ID: 32388113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.
    Milite C; Amendola G; Nocentini A; Bua S; Cipriano A; Barresi E; Feoli A; Novellino E; Da Settimo F; Supuran CT; Castellano S; Cosconati S; Taliani S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1697-1710. PubMed ID: 31537132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
    Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic Anhydrase Inhibitory Potential of 1,2,4-triazole-3-thione Derivatives of Flurbiprofen, Ibuprofen and 4-tert-butylbenzoic Hydrazide: Design, Synthesis, Characterization, Biochemical Evaluation, Molecular Docking and Dynamic Simulation Studies.
    Abbas S; Zaib S; Rahman SU; Ali S; Hameed S; Tahir MN; Munawar KS; Shaheen F; Abbas SM; Iqbal J
    Med Chem; 2019; 15(3):298-310. PubMed ID: 30324884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives.
    Vanjare BD; Choi NG; Eom YS; Raza H; Hassan M; Lee KH; Kim SJ
    Mol Divers; 2023 Feb; 27(1):193-208. PubMed ID: 35344136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, carbonic anhydrase enzyme inhibition evaluations, and anticancer studies of sulfonamide based thiadiazole derivatives.
    Bahadur A; Iqbal S; Muneer S; Alsaab HO; Awwad NS; Ibrahium HA
    Bioorg Med Chem Lett; 2022 Feb; 57():128520. PubMed ID: 34965467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
    Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrazones as new class of carbonic anhydrase inhibitors: Synthesis, kinetics, and ligand docking studies.
    Iqbal S; Saleem M; Azim MK; Taha M; Salar U; Khan KM; Perveen S; Choudhary MI
    Bioorg Chem; 2017 Jun; 72():89-101. PubMed ID: 28390994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.